What is it about?
This article is a review exploring how two powerful data tools—Statistical Process Control (SPC) and Quantitative Microbial Risk Assessment (QMRA)—can work together to improve pharmaceutical manufacturing and hospital safety. SPC (The Monitor): Used originally in engineering, this involves using statistical charts to monitor a process in real-time (like the temperature of a room or the bacterial count in water pipes). It acts like a "check engine" light, alerting staff to small variations before they become big problems. QMRA (The Predictor): This is a public health tool that calculates the specific probability that a certain level of bacteria will actually make someone sick. The article argues that while these tools are usually used separately, combining them creates a "safety loop": SPC detects a rise in bacteria, and QMRA immediately calculates if that rise is dangerous to patients, allowing for instant, data-driven decisions.
Featured Image
Photo by National Cancer Institute on Unsplash
Why is it important?
It Fixes a "Broken" Model: Traditional quality control is "reactive"—it tests the final product at the end of the line. If contamination is found, the whole batch is destroyed, or worse, missed defects reach the patient. This proposed method is "proactive," catching issues during manufacturing. Microbial Risks are High: The article highlights that 45% of pharmaceutical recalls are due to microbiological issues (bacteria/fungi). Reducing this number is critical for public health and industry costs. Regulatory Pressure: New global regulations (like the EMA's Annex 1) require manufacturers to have scientifically robust contamination control strategies. This combined approach satisfies those strict requirements.
Perspectives
This paper represents a shift in mindset from "testing quality in" (checking the final pill) to "designing quality in" (monitoring the process). From a future perspective, this convergence bridges the gap between industrial engineering and clinical safety. Instead of a factory worker simply noting that "bacterial counts are up," this approach allows them to say, "Bacterial counts are up, raising the patient infection risk by 15%," which drives faster, more serious corrective actions. It turns raw data into actionable health warnings.
Independent Researcher & Consultant Mostafa Essam Eissa
Read the Original
This page is a summary of: THE CONVERGENCE OF STATISTICAL PROCESS CONTROL AND QUANTITATIVE MICROBIAL RISK ASSESSMENT: ENHANCING PHARMACEUTICAL QUALITY AND PUBLIC HEALTH SAFETY, Universal Journal of Pharmaceutical Research, November 2025, Society of Pharmaceutical Tecnocrats,
DOI: 10.22270/ujpr.v10i5.1428.
You can read the full text:
Contributors
The following have contributed to this page
